Español
Questions About Cancer? 1-800-4-CANCER
  • Email

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-17 of 17 for your search:
Drug:  omeprazole
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase III
Type: Prevention, Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: QLT-PHO-BAR-01, NCI-V98-1398

2.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 16 and over
Sponsor:
Protocol IDs: BNLI-LY03, EU-98040, NCT00003617

3.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 to 80
Sponsor: NCI, Other
Protocol IDs: CPPDM95-084, P30CA016672, MDA-CPPDM-95084, NCI-T95-0003D, CDR0000064361, T95-0003, NCT00002682

4.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: SWOG-9703, S9703

5.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: EORTC-20961, CRC-EORTC-20961, HOVON-33, NCT00003151

6.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 to 80
Sponsor: Pharmaceutical / Industry
Protocol IDs: IRX-2 2005-A, NCT00210470

7.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 26866138-CAN-1001, NCT00298779

8.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CEPO906A2123, NCT00420615

9.

Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 to 65
Sponsor: Pharmaceutical / Industry
Protocol IDs: NP22676, NCT01001299

10.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-02916, CDR0000685426, CO09908, 8516, P30CA014520, U01CA062491, WCCC-CO-09908, NCT01218620

11.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 12434, NCT01287598

12.

Phase: Phase I
Type: Biomarker/Laboratory analysis
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: ARQ197-A-U158, NCT01517399

13.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: INT12497, U1111-1125-8930, NCT01585623

14.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CTKI258A2119, 2011-001489-16, NCT01596647

15.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 to 55
Sponsor: Pharmaceutical / Industry
Protocol IDs: D5160C00010, NCT02224053

16.

Phase: No phase specified
Type: Prevention
Status: Closed
Age: 35 to 65
Sponsor: NCI
Protocol IDs: NCI-OH-95-C-N029, BICR-OH95-C-N029, NCT00134121

17.

Phase: No phase specified
Type: Natural history/Epidemiology, Prevention
Status: Closed
Age: 30 to 59
Sponsor: Other
Protocol IDs: SMMU20100501, NCT01133951
New Search